These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28166153)

  • 21. Subacute Venous Infarct Mimicking Cerebral Metastasis in 18F-FDG PET/CT.
    Gündoğan C; Yardimci AH; Güneş BY; Çermik TF
    Clin Nucl Med; 2019 Feb; 44(2):e120-e122. PubMed ID: 30516682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET.
    Carra BJ; Clemenshaw MN
    J Nucl Med Technol; 2015 Sep; 43(3):227-8. PubMed ID: 25655343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
    Kitajima K; Miyoshi Y
    Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaplastic Squamous Cell Carcinoma of Breast Demonstrated on 18F-FDG PET/CT.
    Yin H; Xiu Y; Luo R; Zhang H; Shi H
    Clin Nucl Med; 2018 May; 43(5):341-343. PubMed ID: 29432344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of pre- and post-neoadjuvant chemotherapy F-18 FDG PET/CT scans in breast cancer: comparison with MRI.
    Choi EK; Yoo IR; Kim SH; Park SY; O JH; Kang BJ
    Acta Radiol; 2018 Jan; 59(1):41-49. PubMed ID: 28427271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
    J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report: Focal leptomeningeal disease, atypical cancer of unknown primary site.
    Vences MA; Araujo-Chumacero MM; Urrunaga-Pastor D; Barreto L; Rodríguez-Kadota L; Barreto-Acevedo E; Saavedra-Rocha C; Quispe-Huamaní EV
    F1000Res; 2022; 11():885. PubMed ID: 36188732
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary Diffuse Leptomeningeal Melanomatosis of Spine: 18F-FDG PET Findings.
    Ayan A; Akbulut A; Deveci G; Koca G
    Clin Nucl Med; 2019 Feb; 44(2):137-139. PubMed ID: 30516687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
    Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva.
    Guglielmo P; Paderno M; Elisei F; Guerra L; Landoni C; Buda A; Crivellaro C
    Clin Nucl Med; 2019 Jul; 44(7):572-573. PubMed ID: 30985415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More accurate than MRI measurement of tumor size in breast cancer by using the peri-tumoral halo uptake layer method of the
    Park SH; Seo M; Choi HJ; Bae K; Bang M; Jun S
    Hell J Nucl Med; 2018; 21(2):108-114. PubMed ID: 30006644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptomeningeal carcinomatosis and intramedullary spinal cord metastases from lung cancer: detection with FDG positron emission tomography.
    Komori T; Delbeke D
    Clin Nucl Med; 2001 Nov; 26(11):905-7. PubMed ID: 11595839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of diffuse leptomeningeal metastasis in a treated case of medulloblastoma with F-18 FDG PET/CT.
    Tripathi M; Jain N; Jaimini A; Garg G; D'souza MM; Sharma R; Grover RK; Mondal A
    Clin Nucl Med; 2009 Aug; 34(8):530-2. PubMed ID: 19617737
    [No Abstract]   [Full Text] [Related]  

  • 37. PET/CT Imaging for Monitoring Recurrence and Evaluating Response to Treatment in Breast Cancer.
    Lei L; Wang X; Chen Z
    Adv Clin Exp Med; 2016; 25(2):377-82. PubMed ID: 27627573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG PET, PET/CT, and breast cancer imaging.
    Rosen EL; Eubank WB; Mankoff DA
    Radiographics; 2007 Oct; 27 Suppl 1():S215-29. PubMed ID: 18180228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG PET/CT in Recurrent Glioblastoma Multiforme With Leptomeningeal and Diffuse Spinal Cord Metastasis.
    Malik D
    Clin Nucl Med; 2021 Feb; 46(2):138-139. PubMed ID: 33234937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
    Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.